| SangViper vs Heihachi | 26–43 | 37.68% |
| SangViper vs Kazuya | 27–38 | 41.54% |
| SangViper vs Jin | 22–32 | 40.74% |
| SangViper vs Dragunov | 13–35 | 27.08% |
| SangViper vs Bryan | 19–27 | 41.30% |
| SangViper vs Steve | 17–28 | 37.78% |
| SangViper vs King | 12–28 | 30.00% |
| SangViper vs Reina | 17–23 | 42.50% |
| SangViper vs Yoshimitsu | 6–21 | 22.22% |
| SangViper vs Lidia | 10–16 | 38.46% |
| SangViper vs Hwoarang | 13–12 | 52.00% |
| SangViper vs Paul | 8–16 | 33.33% |
| SangViper vs Devil Jin | 6–17 | 26.09% |
| SangViper vs Victor | 7–16 | 30.43% |
| SangViper vs Law | 11–11 | 50.00% |
| SangViper vs Eddy | 5–12 | 29.41% |
| SangViper vs Jun | 2–14 | 12.50% |
| SangViper vs Lili | 8–7 | 53.33% |
| SangViper vs Lars | 2–13 | 13.33% |
| SangViper vs Alisa | 3–9 | 25.00% |
| SangViper vs Asuka | 3–8 | 27.27% |
| SangViper vs Leo | 3–8 | 27.27% |
| SangViper vs Lee | 1–10 | 9.09% |
| SangViper vs Xiaoyu | 2–8 | 20.00% |
| SangViper vs Claudio | 0–10 | 0.00% |
| SangViper vs Feng | 3–5 | 37.50% |
| SangViper vs Shaheen | 2–6 | 25.00% |
| SangViper vs Azucena | 2–6 | 25.00% |
| SangViper vs Kuma | 2–4 | 33.33% |
| SangViper vs Nina | 1–5 | 16.67% |
| SangViper vs Jack-8 | 1–4 | 20.00% |
| SangViper vs Leroy | 0–2 | 0.00% |
| SangViper vs Zafina | 0–2 | 0.00% |
| SangViper vs Raven | 2–0 | 100.00% |
| SangViper vs Panda | 0–1 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.